Neoadjuvant WX-0593 in Resectable ALK-positive or ROS1-positive Non-small Cell Lung Cancer

Clinical trial NCT05765877 · RECRUITING

Trial details

NCT number: NCT05765877
Sponsor: Pingping Song
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer(NSCLC)

Start date: 2023-03-01
Primary completion: 2027-03-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.